The Cardiac prosthetic devices are medical equipment that are implanted during open-heart surgeries to replace damaged or diseased parts of the heart. This include heart valves, such as mechanical heart valves and tissue heart valves, which are implanted to treat severe stenosis or insufficiency of the heart valves. Other cardiac prosthetic devices include ventricular assist devices that help pump blood around the body for those with a severely weakened heart. These prosthetic devices help restore the heart's pumping ability and improve the quality of life of patients.
Cardiac Prosthetic Devices Market is estimated to be valued at USD 8.96 Bn in 2025 and is expected to reach USD 16.7 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.
Key players operating in the Cardiac Prosthetic Devices are Abbott., Artivion, Inc., Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation., Siemens Healthcare Private Limited, LivaNova PLC (sorin group), Asahi Kasei Corporation., OSYPKA MEDICAL, Lepu Medical, MicroPort Scientific Corporation., Vitatron, Koninklijke Philips N.V., Progetti srl, and Shree Pacetronix Ltd.
The Cardiac Prosthetic Devices Market Demand is increasing globally owing to the rising prevalence of cardiovascular diseases and the growing geriatric population. According to the World Health Organization, cardiovascular diseases account for over 17 million deaths worldwide every year. Growing investments and funding for research & development of advanced devices by government and private organizations are also fueling the market growth. Similarly, the expansion of healthcare infrastructure and increasing medical expenditures in developing nations are supporting the global expansion of the cardiac prosthetic devices market. Rising medical tourism in low and middle-income countries is another factor boosting the cardiac prosthetic devices industry.
One of the key trends in the Cardiac Prosthetic Devices Market is the miniaturization of devices. With advancements in medical technology, cardiac prosthetic devices are becoming smaller and less invasive. For example, manufacturers are developing mini heart pumps and tissue engineered heart valves that can be implanted using minimally invasive procedures or catheter-based techniques. Smaller devices offer benefits like reduced surgical risks, shorter recovery times, and better quality of life for patients. This trend towards developing miniature cardiac devices will drive significant growth in the market.
Porter's Analysis
Threat of new entrants: The stringent FDA approval process acts as a barrier for new entrants.
Bargaining power of buyers: Large healthcare providers and group purchasing organizations have significant bargaining power over suppliers.
Bargaining power of suppliers: Majority of suppliers focus on innovation to gain competitive advantage hence suppliers have moderate bargaining power.
Threat of new substitutes: Advancement in alternative therapies like stem cell therapy pose threat of substitution.
Competitive rivalry: Players compete on the basis of product portfolios, innovation and geographic presence.
Geographical Regions
North America holds the largest share of the cardiac prosthetic market accounting for over 40% of the global market value, mainly attributed to the high adoption of advanced technologies and presence of major market players in the region.
The Asia Pacific region is expected to witness the fastest growth over the forecast period attributed to factors such increasing healthcare expenditure, growing burden of CVDs, rising medical tourism and expanding network of healthcare facilities in emerging economies of China and India.
Get This Report in Japanese Language - 心臓人工器官市場
Get This Report in Korean Language -심장 보철 장치 시장
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
